Exclusive: Constructive Bio raises $58M for synbio work, and Nobel laureate joins board

Lei Lei Wu

News Reporter

A UK-based synthetic biology startup has brought in $58 million from private investors to fund its work engineering cell systems that can manufacture new and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Exclusive: Constructive Bio raises $58M for synbio work, and Nobel laureate joins board

Lei Lei Wu

News Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Trump 2.0 blog: Wayback Machine is insufficient for US health data, judge says

Pfizer’s prostate cancer data leak shows promising results in early-stage study

What will pharma's share buyback shopping spree mean for M&A?

Biohaven lands priority review on second-chance application for neurodegenerative drug

Travere plans to seek expanded label for kidney drug despite failed trial

Reducing risk in drug development: The importance of validated MRD testing in lymphoid cancers

Ex­clu­sive: Con­struc­tive Bio rais­es $58M for syn­bio work, and No­bel lau­re­ate joins board

News Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Exclusive: Constructive Bio raises $58M for synbio work, and Nobel laureate joins board